Trade Mark Journal No.2026/004 23 January 2026

UK00004319212 5 January 2026 (5,10)

Image for mark UK00004319212 AFREZZA
Class 5
Pharmaceutical preparations and medicines containing insulin administered by inhalation for the treatment of diabetes, endocrine diseases, and disorders and metabolic diseases and disorders; none of the aforesaid for the treatment of respiratory diseases and disorders, or for the treatment of asthma.
Class 10
Inhalers and inhalation apparatus for the administration and delivery of insulin for the treatment of diabetes, endocrine diseases, and disorders and metabolic diseases and disorders; parts, fittings, components and accessories for all of the aforesaid goods; cartridges for containing insulin for use with inhalers and inhalation apparatus for the treatment of diabetes, endocrine diseases, and disorders and metabolic diseases and disorders; none of the aforesaid for the treatment of respiratory diseases and disorders, or for the treatment of asthma.

MannKind Corporation

Representative: Edwin Coe LLP